ACHN

Achillion Pharmaceuticals, Inc. News Headlines

$15.42
*  
0.175
1.12%
Get ACHN Alerts
*Delayed - data as of Jan. 27, 2015  -  Find a broker to begin trading ACHN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
5 Tiny Biotech Stocks to Own in 2015
1/17/2015 6:51:02 AM - Motley Fool


How To Play Gilead In 2015: It's Going To Be A Bumpy Ride
1/16/2015 1:45:00 PM - Seeking Alpha


I'm Expecting Some Very Positive News Flow From Gilead
1/12/2015 11:55:00 AM - Seeking Alpha


Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks?
1/11/2015 1:04:02 PM - Motley Fool


The Market's Top 10 Stocks of 2014
1/3/2015 9:00:09 AM - Motley Fool


One Reason Achillion Pharmaceuticals (ACHN) Stock is Rising Today
1/2/2015 12:18:00 PM - TheStreet


Biotech Stocks 2014: The Best, Worst and Fastest-Growing
1/2/2015 8:33:00 AM - TheStreet


3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog
12/30/2014 10:41:00 AM - Investopedia


DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
12/30/2014 7:05:00 AM - Seeking Alpha


Could These Tiny Biotech Stocks Double in 2015?
12/30/2014 6:50:04 AM - Motley Fool


Should AbbVie Inc. and Gilead Sciences, Inc. Fear This Biotech Instead of Each Other?
12/28/2014 11:11:04 AM - Motley Fool


Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More
12/26/2014 4:00:00 PM - Seeking Alpha


Wednesday Sector Leaders: Precious Metals, Biotechnology Stocks
12/24/2014 3:02:07 PM - BNK Invest


Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog
12/24/2014 9:48:00 AM - Investopedia


The Hepatitis C Drug Developer That Crushed Gilead Sciences, Inc. in 2014 (Hint: It's Not AbbVie)
12/24/2014 9:03:02 AM - Motley Fool


Pre-Market Most Active for Dec 24, 2014 : RIG, GPRO, SNN, ARCP, FB, SMFG, ACHN, BAC, FCAU, TVIX, CRH, GILD
12/24/2014 8:39:50 AM - NASDAQ.com News


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 PM - Zacks.com


Why Achillion Pharmaceuticals Shares Collapsed by 25% Today
12/23/2014 3:03:03 PM - Motley Fool


Tuesday Sector Laggards: Drugs, Biotechnology Stocks
12/23/2014 1:59:01 PM - BNK Invest


Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations
12/23/2014 10:40:17 AM - Benzinga


Achillion Pharmaceuticals (ACHN) Rises: Stock Adds 9% in Session - Tale of the Tape
12/23/2014 8:44:00 AM - Zacks.com


Health Care Sector Update for 12/23/2014: ACHN, MEIP, ABBV
12/23/2014 8:40:31 AM - MT Newswires


Achillion Pharmaceuticals (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape
12/23/2014 8:21:22 AM - Zacks.com


Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog
12/23/2014 5:00:00 AM - Investopedia


Week Ahead Market Report: December 22, 2014
12/22/2014 3:57:53 PM - BNK Invest